Skip to content

Pre-implantation genetic haplotyping of embryos using next-generation sequencing

Pre-implantation genetic haplotyping of embryos using next-generation sequencing - PGD haplotyping

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42386
Enrollment
266
Registered
2015-12-22
Start date
2016-01-03
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chromosomal anomalies monogenic diseases

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Couple undergoed IVF/PGD treatment for a monogenic disease or chromosomal disorder (diagnosed by aCGH )

Exclusion criteria

Exclusion criteria: Couples unable to give informed consent to all aspects of the study or unable to comply with the protocol.

Design outcomes

Primary

MeasureTime frame
Research phase Percentage invalid results for monogenic disorders in blastomere cells and in trophectoderm cells for chromosomal disorders in in blastomere cells and in trophectoderm cells for chromosomalaneuploidy in blastomere cells and in trophectoderm cells Verification phase Sensitivity of the NGS-based haplotyping method for monogenic disorders in blastomere cells and in trophectoderm cells for chromosomal disorders in in blastomere cells and in trophectoderm cells for chromosomalaneuploidy in blastomere cells and in trophectoderm cells

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)